Diabetes, Digestive, and Kidney Diseases Extramural Research in Arkansas
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $24.0 million to recipients in Arkansas in 17 grants from fiscal 2021 to 2025, 0.3% of the program's national total. University of Arkansas for Medical Sciences received the most, $13.8 million.
- Awarded in Arkansas$24.0 million
- Awards17
- Share of the program0.3%
- Rank among states36th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 6 | $2.2 million |
| FY 2022 | 9 | $4.5 million |
| FY 2023 | 10 | $6.7 million |
| FY 2024 | 12 | $6.1 million |
| FY 2025 | 9 | $4.5 million |
Recipients in Arkansas
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Arkansas for Medical Sciences | Colleges and universities | 9 | $13.8 million |
| Nephropathology Associates, PLC | Small businesses | 5 | $4.6 million |
| Acetaminophen Toxicity Diagnostics, LLC | Small businesses | 1 | $3.5 million |
| SFC Fluidics, Inc. | Small businesses | 1 | $1.9 million |
| Nephsmart LLC | Small businesses | 1 | $274,415 |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Arkansas?
$24.0 million from fiscal 2021 to 2025, across 17 awards. Arkansas ranks 36th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Arkansas?
The largest recipient is University of Arkansas for Medical Sciences, with $13.8 million in 9 awards. Next are Nephropathology Associates, PLC and Acetaminophen Toxicity Diagnostics, LLC.
Can organizations in Arkansas apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Arkansas
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Broadband Equity, Access, and Deployment Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Head Start